ACArvind K. Chaturvedi

Arvind K. Chaturvedi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arvind K. Chaturvedi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Dennis V. Canfield

    Bioaeronautical Sciences Research Laboratory (AAM-610), Civil Aerospace Medical Institute, Federal Aviation Administration, U.S. Department of Transportation, P. O. Box 25082, Oklahoma City, Oklahoma 73125

    3 shared publications
  • Dennis V. Canfield

    US Department of Transportation, Toxicology and Accident Research Laboratory (AAM-610), Aeromedical Research Division, Civil Aerospace Medical Institute, Federal Aviation Administration, P.O. Box 25082, Oklahoma City, OK 73125-5066, USA

    2 shared publications
  • Dudley R. Smith

    US Department of Transportation, Toxicology and Accident Research Laboratory (AAM-610), Aeromedical Research Division, Civil Aerospace Medical Institute, Federal Aviation Administration, P.O. Box 25082, Oklahoma City, OK 73125-5066, USA

    2 shared publications
  • H K Boren

    1 shared publication
  • J W Soper

    Toxicology and Accident Research Laboratory, Aeromedical Research Division, Civil Aeromedical Institute, Federal Aviation Administration, U.S. Department of Transportation, Oklahoma City, OK, USA

    1 shared publication
  • S J Veronneau

    1 shared publication

Latest Publications

  • A fatality caused by accidental production of hydrogen sulfide

    by Arvind K. Chaturvedi, Dudley R. Smith, Dennis V. Canfield


    • 1 September 2001
      • Vol. 72  (9) , 813-5

    Abnormal glucose levels found in transportation accidents.

    by D V Canfield, A K Chaturvedi, H K Boren, S J Veronneau, V L White

    The Federal Aviation Administration's Office of Aerospace Medicine is responsible for the certification of pilots with diabetic conditions. The present study evaluated the use of postmortem vitreous humor and urine glucose levels in transportation accident fatalities as indicators of potentially incapacitating medical conditions or performance impairment. Vitreous humor and/or urine from 192 accident fatalities were analyzed for glucose using a hexokinase method. Cases with values below the lower limit of detection (10 mg x dl(-1)) and above 3 standard deviations (SD) from the mean were not included in the final statistics. All cases more than 5 SD above the mean were deemed abnormal and a full case history was evaluated based on the available medical history. The mean vitreous humor glucose concentration was 30+/-21 mg x dl(-1) (N=98), while it was 27+/-16 mg x dl(-1) in urine (N=127). Of the 192 cases, 9 were identified as having abnormal glucose levels. Abnormal glucose levels were found in 5 of the 8 cases with a known diabetic condition. Glycosuria or low renal threshold was reported in 2 fatal pilots; 1 of these pilots had an abnormal glucose level. Hyperglycemia can be established from the vitreous humor and urine glucose levels. All of the abnormal glucose cases detected were previously identified during the medical certification process or had a medical reason for the abnormal level. Elevated vitreous humor and urine glucose levels have proven useful in identifying individuals with a pre-existing diabetic condition that might have been a factor in the accident.


    • 1 December 2000
      • Vol. 71  (12) , 1206-9

    Prevalence of chlorpheniramine in aviation accident pilot fatalities, 1991-1996.

    by J W Soper, A K Chaturvedi, D V Canfield

    Chlorpheniramine is known to cause drowsiness, and this side effect has a potential to impair performance and could be a factor in accidents. Therefore, to establish the prevalence of this drug in pilot fatalities of aviation accidents, a postmortem toxicology database--maintained at the Civil Aeromedical Institute--was examined for the presence of chlorpheniramine in the fatalities, occurred during 1991-1996. There were 47 (2.2%) accidents involving chlorpheniramine. Of these, 16 had only chlorpheniramine at 109 ng.ml-1 (n = 4) in blood and 1412 ng.g-1 (n = 12) in liver. Other drugs were also present in the remaining 31 cases, wherein chlorpheniramine concentrations were 93 ng.ml-1 (n = 18) in blood and 747 ng.g-1 (n = 12) in liver. Ninety-five percent of all quantitated blood values were at or above the therapeutic level (10 ng.ml-1), giving a 100 ng.ml-1 (n = 21) mean blood value. The drug's mean liver concentration from all cases was 1080 ng.g-1 (n = 24). The average blood value was approximately 10 times higher than the therapeutic value. The presence of other drugs did not appear to significantly alter the blood chlorpheniramine level, but no such correlation could be established with the hepatic value. The approximate 10-fold increase in the liver concentration was consistent with the general trend of drug distribution in the hepatic compartment. However, the contribution of postmortem redistribution of the drug to alter its concentration cannot be entirely ruled out. This study suggests that chlorpheniramine was present in some aviation fatalities at levels higher than therapeutic levels.


    • 1 March 1997
      • Vol. 68  (3) , 230-3

    Role of metabolites in aviation forensic toxicology.

    by A K Chaturvedi, D V Canfield

    In aviation accident investigations, specimens from fatal aircraft victims are analyzed for drugs. The presence of drugs suggests possible associated medical conditions for which they might have been taken. As drugs are mostly present in therapeutic to subtherapeutic levels in aviation forensic toxicology cases, determination of parent drugs and their metabolites in multispecimens is of significance. Although chemically reactive metabolites are difficult to detect, physiologically active and inactive metabolites can be analyzed. Selective and sensitive techniques are available, but unavailability of metabolite reference standards, endogenous substance interference, and low tissue metabolite levels limit the analyses. However, the majority of primary metabolites can be effectively characterized/quantitated. Demonstrating the presence of drug (e.g., terfenadine, cocaine, THC) metabolites provides a compelling evidence for exposure to the parent drug and facilitates interpretation of results, particularly when the metabolites are active. Such analyses are not as helpful if the metabolites are also available as drugs (e.g., diazepam, temazepam, oxazepam).